Themes

This study looks at emerging trends in the radiosurgery market and the residual impact of the financial crisis from both a market and an end-user hospital perspective. Stereotactic Radiosurgery (SRS) is an advanced form of radiotherapy capable of synchronizing tumor detection, surgical guidance, and radiation delivery components in a manner that ca...

This market insight on contract sales and marketing organisations throws light on the changing dynamics and the opportunities that lie ahead for these organisations in the future.

This research service provides insights into M&A activities, trends and strategic analysis in the pharma- biotech space.

This research service provides the market information on the global radiotherapy and radiosurgery markets, with specific focus on the United States.

This strategic analysis identifies the current trends in scientific business intelligence (Sci-BI) in pharmaceutical and biotechnology markets. Major global healthcare trends are analyzed and the impacts on Sci-BI are delineated. A close look at drivers and restraints in the Sci-BI space revealed interesting growth stimulators while also identifyin...

This research service covers the U.S. biotechnology: therapeutic monoclonal antibodies market from 2004-2014. Included are a disease overviews, technology trends, total market revenue forecasts, market segment revenue forecasts, and market share analysis. The market is segmented by product usage: oncology, autoimmune and inflammatory disorders, or...

This research service examines the contract research organization market highlighting on what pharmaceutical and biotechnology companies want. The research service highlights services what pharmaceutical and biotech companies want from the contract research organizations (CROs) and the criteria they use in selecting CROs. The countries covered in t...

This Research Service gives an extensive coverage of the Australian and New Zealand Biotechnology Industries. The study has be classified based on five key value drivers of the industry namely the Environmental Factors, Research and Development, Branding, Partnerships and Distribution. Every value driver has been disucced at length with statistical...

The research service profiles the top 10 biotechnology companies and incorporates a unique risk-return model to analyze the research and development pipeline of these companies. Cost-Benefit analysis for these companies and the industry has also been undertaken in this research service.